ANAVEX LIFE SCIENCES CORP. - 8-K Filing
Anavex Life Sciences received a delinquency notification from Nasdaq on May 20, 2026 for failing to file its Form 10-Q for the quarter ended March 31, 2026. The company has until July 20, 2026 to submit a plan to regain compliance with Nasdaq Listing Rule 5250(c)(1). (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $AVXL